Investing
Top 10 Pre-Market Analyst Calls (ADBE, CRUS, DVA, EEQ, EQR, IP, LNCR, RGLD, WIN, BRL, MFLX, MYL, TEVA, WPI)
Published:
Last Updated:
These are not the only analyst impact calls, but these are the top research notes that a673b.bigscoots-temp.com is focusing on:
- Adobe Systems (ADBE) raised to Buy at Deutsche Bank.
- Cirrus Logic (CRUS) raised to Buy at Jefferies.
- DaVita (DVA) raised to Buy at Oppenheimer.
- Embarq (EQ) raised to Overweight at J.P.Morgan.
- Equity Residential (EQR) raised to Overweight at Lehman.
- International Paper (IP) raised to Outperform at Credit Suisse.
- Lincare (LNCR) downgraded to Neutral at Oppenheimer.
- Royal Gold (RGLD) raised to Overweight at HSBC.
- Windstream (WIN) downgraded to Underweight at J.P.Morgan.
- BANC OF AMERICA ON DRUGS: Barr Pharma (BRL) started as Buy; Multi-Fineline (MFLX) started as Buy; Mylan Labs (MYL) started as Buy; Teva Pharma (TEVA) started as Buy; Watson Pharma (WPI) started as neutral; ZymoGenetics (ZGEN) downgraded to Neutral.
Jon C. Ogg
December 18, 2007
Jon Ogg can be reached at [email protected]; he produces the SPECIAL SITUATION newsletter and he does not own securities in the companies he covers.
Is Your Money Earning the Best Possible Rate? (Sponsor)
Let’s face it: If your money is just sitting in a checking account, you’re losing value every single day. With most checking accounts offering little to no interest, the cash you worked so hard to save is gradually being eroded by inflation.
However, by moving that money into a high-yield savings account, you can put your cash to work, growing steadily with little to no effort on your part. In just a few clicks, you can set up a high-yield savings account and start earning interest immediately.
There are plenty of reputable banks and online platforms that offer competitive rates, and many of them come with zero fees and no minimum balance requirements. Click here to see if you’re earning the best possible rate on your money!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
